Prescription drug · ANDA
Lidocaine 5% NDC 68071-3620
Lidocaine 700 mg/1 · Patch · Topical · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-3620-3 | 68071362003 | 30 POUCH in 1 PACKAGE (68071-3620-3) / 1 PATCH in 1 POUCHMarketed from Jun 13, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lidocaine 5%
- Generic name (nonproprietary)
- lidocaine 5%
- Active ingredients
- Lidocaine — 700 mg/1
- Dosage form
- Patch
- Route
- Topical
- Labeler
- NuCare Pharmaceuticals,Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209190
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 68071-3620_1ac8b5d1-7474-fb2c-e063-6394a90a1917SPL ID 1ac8b5d1-7474-fb2c-e063-6394a90a1917SPL set ID 1ac8a196-010f-a986-e063-6294a90a948fRxCUI 1745091UNII 98PI200987UPC 0368071362039
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071362003followed by a unit qualifier and the quantityPackage 68071-3620-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 209190
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | Asclemed USA, Inc. | 76420-899 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | A-S Medication Solutions | 50090-7857 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | St. Mary's Medical Park Pharmacy | 60760-657 |
| Lidox 5 Patchlidocaine 5% patch | Lidocaine 50 mg/g | PatchTopical | Injecta Medcial LLC | 87234-0505 |
| Lidocaine 5% Patchlidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | Medcore LLC | 82461-611 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | REMEDYREPACK INC. | 70518-4487 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | YARAL Pharma Inc. | 82347-0505 |
| Lidocan VIIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-900 |
| Lidocan IVlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-910 |
| Lidocanlidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | PURETEK CORPORATION | 59088-905 |
| Tridacaine IIIlidocaine | Lidocaine 50 mg/g | PatchTopical | Trifluent Pharma LLC | 73352-835 |
| Lidocan IIIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-907 |
| Tridacaine XLlidocaine | Lidocaine 50 mg/g | PatchTopical | Trifluent Pharma LLC | 73352-845 |
| Lidocan Vlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-909 |
| Lidocan VIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-911 |